Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CTS-1027 Plus SOC in HCV Null-Responders
NCT01051921Phase 2Completed
- Sponsor
- Conatus Pharmaceuticals Inc.
- Start
- Jan 2010
- Primary completion
- Nov 2011
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 2 trial of CTS-1027 in hepatitis C (HCV), sponsored by Conatus Pharmaceuticals Inc.. Started Jan 2010; status: completed.
02
Drugs
CTS-1027
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01051921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01051921.